EUVIMEDEUVIMED entdecken
Crossref

114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria

A. Gant, M. Ndung’u

Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103166

DOI: 10.1016/j.japh.2026.103166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von A. Gant und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gant, A., & Ndung’u, M. (2026). 114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria. Journal of the American Pharmacists Association, 66(4), 103166. https://doi.org/10.1016/j.japh.2026.103166

Vancouver

Gant A, Ndung’u M. 114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria. Journal of the American Pharmacists Association. 2026;66(4):103166. doi:10.1016/j.japh.2026.103166

BibTeX
@article{Gant2026,
  author = {Gant, A. and Ndung’u, M.},
  title = {114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  volume = {66},
  number = {4},
  pages = {103166},
  doi = {10.1016/j.japh.2026.103166}
}
Kostenlos starten →